ID A0A1S3W2D5_ERIEU Unreviewed; 1459 AA.
AC A0A1S3W2D5;
DT 12-APR-2017, integrated into UniProtKB/TrEMBL.
DT 12-APR-2017, sequence version 1.
DT 27-MAR-2024, entry version 27.
DE SubName: Full=LOW QUALITY PROTEIN: alpha-2-macroglobulin-like {ECO:0000313|RefSeq:XP_016040550.1};
GN Name=LOC103107053 {ECO:0000313|RefSeq:XP_016040550.1};
OS Erinaceus europaeus (Western European hedgehog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Eulipotyphla; Erinaceidae; Erinaceinae;
OC Erinaceus.
OX NCBI_TaxID=9365 {ECO:0000313|Proteomes:UP000079721, ECO:0000313|RefSeq:XP_016040550.1};
RN [1] {ECO:0000313|RefSeq:XP_016040550.1}
RP IDENTIFICATION.
RG RefSeq;
RL Submitted (NOV-2023) to UniProtKB.
CC -!- SUBUNIT: Monomer. {ECO:0000256|ARBA:ARBA00011245}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|ARBA:ARBA00004613}.
CC -!- SIMILARITY: Belongs to the protease inhibitor I39 (alpha-2-
CC macroglobulin) family. {ECO:0000256|ARBA:ARBA00010952}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR RefSeq; XP_016040550.1; XM_016185064.1.
DR eggNOG; KOG1366; Eukaryota.
DR InParanoid; A0A1S3W2D5; -.
DR OrthoDB; 2970602at2759; -.
DR Proteomes; UP000079721; Unplaced.
DR GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR CDD; cd02897; A2M_2; 1.
DR Gene3D; 1.50.10.20; -; 1.
DR Gene3D; 2.20.130.20; -; 1.
DR Gene3D; 2.60.120.1540; -; 1.
DR Gene3D; 2.60.40.1930; -; 2.
DR Gene3D; 2.60.40.1940; -; 1.
DR Gene3D; 2.60.40.690; Alpha-macroglobulin, receptor-binding domain; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR InterPro; IPR009048; A-macroglobulin_rcpt-bd.
DR InterPro; IPR036595; A-macroglobulin_rcpt-bd_sf.
DR InterPro; IPR011625; A2M_N_BRD.
DR InterPro; IPR041813; A2M_TED.
DR InterPro; IPR047565; Alpha-macroglob_thiol-ester_cl.
DR InterPro; IPR011626; Alpha-macroglobulin_TED.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR014756; Ig_E-set.
DR InterPro; IPR001599; Macroglobln_a2.
DR InterPro; IPR019742; MacrogloblnA2_CS.
DR InterPro; IPR002890; MG2.
DR InterPro; IPR041555; MG3.
DR InterPro; IPR040839; MG4.
DR InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR PANTHER; PTHR11412; MACROGLOBULIN / COMPLEMENT; 1.
DR PANTHER; PTHR11412:SF133; MURINOGLOBULIN-1-RELATED; 1.
DR Pfam; PF00207; A2M; 1.
DR Pfam; PF07703; A2M_BRD; 1.
DR Pfam; PF07677; A2M_recep; 1.
DR Pfam; PF01835; MG2; 1.
DR Pfam; PF17791; MG3; 1.
DR Pfam; PF17789; MG4; 1.
DR Pfam; PF07678; TED_complement; 1.
DR SMART; SM01360; A2M; 1.
DR SMART; SM01359; A2M_N_2; 1.
DR SMART; SM01361; A2M_recep; 1.
DR SMART; SM01419; Thiol-ester_cl; 1.
DR SUPFAM; SSF49410; Alpha-macroglobulin receptor domain; 1.
DR SUPFAM; SSF81296; E set domains; 1.
DR SUPFAM; SSF48239; Terpenoid cyclases/Protein prenyltransferases; 1.
DR PROSITE; PS00477; ALPHA_2_MACROGLOBULIN; 1.
PE 3: Inferred from homology;
KW Glycoprotein {ECO:0000256|ARBA:ARBA00023180};
KW Protease inhibitor {ECO:0000256|ARBA:ARBA00022690};
KW Reference proteome {ECO:0000313|Proteomes:UP000079721};
KW Secreted {ECO:0000256|ARBA:ARBA00022525};
KW Serine protease inhibitor {ECO:0000256|ARBA:ARBA00022900};
KW Signal {ECO:0000256|ARBA:ARBA00022729}.
FT DOMAIN 458..606
FT /note="Alpha-2-macroglobulin bait region"
FT /evidence="ECO:0000259|SMART:SM01359"
FT DOMAIN 723..813
FT /note="Alpha-2-macroglobulin"
FT /evidence="ECO:0000259|SMART:SM01360"
FT DOMAIN 1359..1446
FT /note="Alpha-macroglobulin receptor-binding"
FT /evidence="ECO:0000259|SMART:SM01361"
SQ SEQUENCE 1459 AA; 163867 MW; 3FA4A14097A53EA2 CRC64;
MGKDRYTMSC LGVTYLALVS ATTLVLGNLQ YMVMVPYVLP TEIPVKICLL LRYLNETVTV
SASLQHMERN LIDDLVIDKD LFHCISFTLP RSLSSKSERY LSVMIKGSTH EFHDAKKVLI
QEKGSLIFIQ TDKQIYTPGQ SVKFRIVSMD EKFYPLHEVV SLSYMXDPEM NRIMQWQNVE
LENGLTQLSF TVSSEPIKGS YKIVIMKQSG EKTEHSFTVE EYVLPKFEVQ VKVPKLINIL
DTELNVSVCG IYSYRKPVSG NVTLRIEPIH MVPAYYFKNY AWPTYEEVNQ PLDIHGCITR
QLNTNVFHLK TAEFKIEYLH VEAKITEEGT GLEIYGTGKT YVTKIITSLT FVKVDSYFRR
GIPFTGQVRL VDRKGTPIPN ERIFIDSTAA NHHSNAITDE HGLAQFSIDT MNVMSSSLSV
RVYHKHQSSC SWNRCWREEY QDAYRTVYHV FSLSNNAVKL EAVAGILPCN QIQTIQAHYI
LNEQALGELK EMTFYYLIMA KGNIRKTGTY NLSMKAGESS GHFSMSFPVE AEFAPAVQLL
IYAILPDGEV IGDKAKYEIE NCLSNKVDLS FNPTQSLPAS QALLQVTASP HSLCAVRAVD
QSVLLKKPEA ELSATSIYNL LPKTDRSGLM NSLSKWQKDD KDCVKRDIVH NDDPNPTISR
SEEQDIYIFI RDMNLVAFTN LKLKHPKFCS KALIMYSREK DYVVFANAPP SSIVTVRKYF
PETWIWDLVT INSSGVAELR VTVPDTITEW KAGVFCLSNN TGFGISPTAS LRAFQPFFLE
VTMPYSVIRG EAFTLKATVF NYVPKCIQVS VQLAPSPDYM AIPVEKEESH CLCTNGRLTV
SWLVIPKSLG NVNFTVSAET VTSSELCGAE VATLPENGRR DTVVKLLLVE PEGIKKEHTF
ISLLCASDDR LPEQLSLTLP PKIVEESTRA SFSVFGDILS SAIKNTQNLL QMPFGCGEQN
MVLFAPNIYV LKYLNETQQV TEEIKSKAIG YLHAGYQRQL NYKHKDGSYS AFGDKDGKTQ
GNTWLTAFVL KTLAQAQAVI FIDENHISEA LIWLSRKQTM SGCFSRSGTL LNNALKGGVQ
DEVTLSAYIT IALLEIPLPV TNPVVQKALT CLESFWNKTK EKVDSHVYTK ALLAYAFALA
GDQDKRREIL KSLDEDAIKE DNTMHWESPH KPRAPKNDFH TIQASSAEVE MTSYVLLAYL
TTRSALTSED LTSATYIVKW LTKQQNPYGG FSSTQDTVVA LQALSRYGAA TFAKSEKDIL
VTIQSSKTFS TKFQVNSTNR LLLQQVSLPD LPGEYSIQVS GEGCVYTQAV LKYNVFLEKK
ESAFILQAQT VPQICDGPES HKSFQISLEV SYIGNRPVSN MVIVDVKMIS GFIPLKPTVK
MLEKSSSVSR TEVTTNNVLI YLEQVTNQTL SFSFMVVQDI PVRDLKPAIV KVYDYYETDE
VAFAEYNDPC STNSEQGNN
//